You are here
Chronic myeloid leukemia and pregnancy: patient and partner perspectives
Marlise R. Luskin Published online: 23 Jul 2018
As CML is now a controllable, chronic condition for most patients, focus turns to the impact of the disease and TKI treatment on quality of life. For young patients with CML, the opportunity to raise a family is a frequent goal. However, the TKIs that have dramatically improved CML outcomes are teratogenic, meaning that women with CML who want to conceive or who become pregnant must stop their TKI which may, in turn, comprise treatment of the CML.